COVID-19 has undoubtedly changed how assisted conception treatment is being offered. Travel restriction has prevented some couples from pursuing treatment outside their own countries. The financial impact has made it necessary for some of our patients to delay treatment. Less expensive treatment options are becoming more popular. Everywhere, tele-medicine is emerging, and virtual clinics are growing in demand. The transport of donated gametes from one country to another is happening more often to overcome the travel restrictions and quarantine requirement. Vaccination prior to conception or during pregnancy are frequently asked questions. Clinics have to modify their practice to meet new expectations. Consequently, ASPIRE has put together this webinar on “The impact of COVID-19 pandemic on fertility treatments” by inviting three distinguished speakers to address these various issues.
Date and Time: Saturday, 4 December 2021
Time: 5pm-6.30pm (GMT+8)
This webinar is supported by Organon.
Chair: Tin-Chiu Li (Hong Kong)
1. The Impact of COVID-19 on Medical Treatment in General and on Fertility Treatment in Particular
Speaker: Dr Vanessa Vergara (Madrid, Spain)
Medical Coordinator at IVI Clinic Madrid, IVI Clinic Madrid
2. Delay in IVF Treatment up to 6 months Does not Affect Pregnancy Outcomes
Speaker: Dr Phillip A Romanski (New York City)
Fellow of Reproductive Endocrinology & Infertility in Obstetrics and Gynecology, Weill Cornell Medical College
3. Prioritizing IVF Treatment in the Post-COVID-19 Era
Speaker: Professor Siladitya Bhattacharya (Aberdeen)
Professor and Head of School of Medicine Medical Sciences and Nutrition at the
University of Aberdeen
This webinar is free for all to access.
A certificate of attendance will be provided to participants who have attended at least 50% of the webinar.